Logo image of EKG.CA

CARDIOCOMM SOLUTIONS INC (EKG.CA) Stock Fundamental Analysis

TSX-V:EKG - TSX Venture Exchange - CA14159N2086 - Common Stock - Currency: CAD

0.015  +0 (+50%)

Fundamental Rating

1

EKG gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 6 industry peers in the Health Care Technology industry. EKG has a bad profitability rating. Also its financial health evaluation is rather negative. EKG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year EKG has reported negative net income.
In the past year EKG has reported a negative cash flow from operations.
In the past 5 years EKG reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: EKG reported negative operating cash flow in multiple years.
EKG.CA Yearly Net Income VS EBIT VS OCF VS FCFEKG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200K -400K -600K -800K -1M

1.2 Ratios

EKG has a Return On Assets (-56.72%) which is in line with its industry peers.
Industry RankSector Rank
ROA -56.72%
ROE N/A
ROIC N/A
ROA(3y)-9.76%
ROA(5y)-75.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EKG.CA Yearly ROA, ROE, ROICEKG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1K 2K 3K 4K

1.3 Margins

EKG's Gross Margin of 92.11% is amongst the best of the industry. EKG outperforms 100.00% of its industry peers.
EKG's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for EKG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 92.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y5.68%
EKG.CA Yearly Profit, Operating, Gross MarginsEKG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100

More info and screens

1

2. Health

2.1 Basic Checks

EKG does not have a ROIC to compare to the WACC, probably because it is not profitable.
EKG has about the same amout of shares outstanding than it did 1 year ago.
EKG has more shares outstanding than it did 5 years ago.
The debt/assets ratio for EKG is higher compared to a year ago.
EKG.CA Yearly Shares OutstandingEKG.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
EKG.CA Yearly Total Debt VS Total AssetsEKG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M

2.2 Solvency

Based on the Altman-Z score of -147.80, we must say that EKG is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -147.80, EKG is doing worse than 85.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -147.8
ROIC/WACCN/A
WACC8.61%
EKG.CA Yearly LT Debt VS Equity VS FCFEKG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200K -200K 400K -400K -600K -800K

2.3 Liquidity

EKG has a Current Ratio of 0.56. This is a bad value and indicates that EKG is not financially healthy enough and could expect problems in meeting its short term obligations.
EKG has a Current ratio of 0.56. This is comparable to the rest of the industry: EKG outperforms 42.86% of its industry peers.
EKG has a Quick Ratio of 0.56. This is a bad value and indicates that EKG is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of EKG (0.47) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.56
Quick Ratio 0.47
EKG.CA Yearly Current Assets VS Current LiabilitesEKG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M

More info and screens

0

3. Growth

3.1 Past

EKG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -140.00%.
EKG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -43.42%.
The Revenue has been decreasing by -4.01% on average over the past years.
EPS 1Y (TTM)-140%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)-43.42%
Revenue growth 3Y1.63%
Revenue growth 5Y-4.01%
Sales Q2Q%-44.4%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EKG.CA Yearly Revenue VS EstimatesEKG.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M
EKG.CA Yearly EPS VS EstimatesEKG.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
EKG.CA Price Earnings VS Forward Price EarningsEKG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EKG.CA Per share dataEKG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0 0 0 0 0 0 0 0 0 0

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EKG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CARDIOCOMM SOLUTIONS INC

TSX-V:EKG (3/7/2025, 7:00:00 PM)

0.015

+0 (+50%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-28 2024-11-28
Earnings (Next)04-28 2025-04-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners26.08%
Ins Owner ChangeN/A
Market Cap2.90M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.45
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -56.72%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 92.11%
FCFM N/A
ROA(3y)-9.76%
ROA(5y)-75.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y5.68%
F-Score3
Asset Turnover1.6
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.56
Quick Ratio 0.47
Altman-Z -147.8
F-Score3
WACC8.61%
ROIC/WACCN/A
Cap/Depr(3y)17.61%
Cap/Depr(5y)29.38%
Cap/Sales(3y)0.54%
Cap/Sales(5y)0.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-140%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-43.42%
Revenue growth 3Y1.63%
Revenue growth 5Y-4.01%
Sales Q2Q%-44.4%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-185.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-108.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-108.94%
OCF growth 3YN/A
OCF growth 5YN/A